£15.0M
The Cambridge-based biotechnology company secured the Series A financing from backers including BRAIN Biotech AG and Seneca Partners.
S
SolasCure
SolasCure develops wound cleaning products using an enzyme derived from medical maggots.
Cambridge, UK—Founded 2017
£15.0MTotal raised
Biotechnology company developing wound care products based on natural enzymes.
Filed accounts
Cash at bank
Members only
Net current assets
Members only
Total assets less current liabilities
Members only
Net assets
Members only
Shareholders' funds
Members only
Fixed assets
Members only
Cash, assets and headcount from SolasCure's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Categories
Founders
SB
Sam Bakri
Founder and CEO